BlackRock
CNTB

BlackRock’s Connect Biopharma Holdings CNTB Stock Holding History

BlackRock’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,838
Closed -$2.65K – 5402
2024
Q3 		$2.65K Sell
1,838
-102,053
-98% -$125K ﹤0.01% 5095
2024
Q2 		$158K Sell
103,891
-936,176
-90% -$1.54M ﹤0.01% 4594
2024
Q1 		$1.81M Hold
1,040,067
– – ﹤0.01% 4032
2023
Q4 		$1.23M Sell
1,040,067
-85,195
-8% -$101K ﹤0.01% 4197
2023
Q3 		$922K Hold
1,125,262
– – ﹤0.01% 4271
2023
Q2 		$1.27M Hold
1,125,262
– – ﹤0.01% 4221
2023
Q1 		$1.13M Hold
1,125,262
– – ﹤0.01% 4300
2022
Q4 		$977K Sell
1,125,262
-301,166
-21% -$248K ﹤0.01% 4419
2022
Q3 		$1.84M Sell
1,426,428
-8,532
-0.6% -$10.3K ﹤0.01% 4232
2022
Q2 		$1.25M Sell
1,434,960
-801,432
-36% -$1.18M ﹤0.01% 4443
2022
Q1 		$6.75M Buy
2,236,392
+92,632
+4% +$391K ﹤0.01% 3789
2021
Q4 		$11M Sell
2,143,760
-306,305
-13% -$3.4M ﹤0.01% 3615
2021
Q3 		$59.4M Sell
2,450,065
-8,067
-0.3% -$183K ﹤0.01% 2549
2021
Q2 		$48M Buy
2,458,132
+7,742
+0.3% +$129K ﹤0.01% 2731
2021
Q1 		$45.3M Buy
+2,450,390
New +$41.7M ﹤0.01% 2682

Other funds holding CNTB

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $8.15B AUM 20.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CC
Callan Capital La Jolla, California $1.35B AUM 8.35% 1-Year Est. Return
CCG
Catalina Capital Group Torrance, California $168M AUM 16.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
GM
GeoWealth Management Chicago, Illinois $2.78B AUM 15.76% 1-Year Est. Return

BlackRock's CNTB Position: Q4 2024 in Review

BlackRock sold out of Connect Biopharma Holdings (CNTB) in Q4 2024, closing a stake of 1,838 shares — an estimated $2.65K sold.

BlackRock first reported a position in CNTB in Q1 2021 and held it in 15 quarters. The position peaked at $59.4M in Q3 2021. 14 funds tracked by Wall St. Rank hold CNTB as of Q4 2024.

  • BlackRock reported no remaining Connect Biopharma Holdings position as of Q4 2024 after selling out during the quarter.
  • BlackRock sold 1,838 Connect Biopharma Holdings shares in Q4 2024, an estimated $2.65K.
  • BlackRock first reported a position in Connect Biopharma Holdings in Q1 2021 and held it in 15 quarters.
  • BlackRock's Connect Biopharma Holdings position peaked at $59.4M in Q3 2021.
  • 14 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q4 2024.

Based on BlackRock's 13F filing for Q4 2024, filed 7 Feb 2025.